Single-Cell Atlas Links Childhood Crohn’s Cell Signatures to Severity and Anti‑TNF Resistance

Overview

• The study built two single-cell atlases (pediCD and FGID) from small-intestine biopsies using single-cell RNA sequencing of 14 untreated children, repeat biopsies from eight after therapy, and 13 non-inflammatory controls.
• The team released ARBOL, a publicly available computational tool that hierarchically splits cells into distinct 'states' to map cellular composition and identify diagnostic signatures.
• At diagnosis, more severe pediatric Crohn’s correlated with higher levels of proinflammatory immune cells—specific T cells, cytotoxic natural killer cells, and subsets of monocytes and macrophages—and fewer metabolically specialized intestinal epithelial cells.
• Combining the pediatric atlas with follow-up samples and adult single-cell data showed anti‑TNF therapy is associated with a shift in children’s intestinal cell ecosystems toward an adult-like, treatment-resistant state.
• Authors warn the Seattle-based cohort size, strict inclusion criteria, limited follow-up, and lack of integrated genetic and microbiome data limit clinical application now and require larger, geographically diverse validation studies while the public atlases enable replication efforts.